Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and...

Original Article from The New England Journal of Medicine — Early Outpatient Treatment for Covid-19 with Convalescent...

Mashup Score:1

www.medrxiv.org

| medRxiv - 1 day

Mashup Score:1

medRxiv – The Preprint Server for Health...

This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and...

PURPOSE Despite reported widespread use of dietary supplements during cancer treatment, few empirical data with regard to their safety or efficacy exist. Because of...

CCC19 is a consortium of 120+ organizations that are working together to collect data about patients with cancer who have been diagnosed with...

PURPOSE Vaccine-induced neutralizing antibodies (nAbs) play a critical role in protection from SARS CoV-2. Patients with B-cell malignancies including myeloma are at increased risk...

COVID-19 in patients with hematological diseases is associated with a high mortality. Moreover, preventive vaccination demonstrated reduced efficacy and the knowledge on influencing factors...

e19513 Background: Patients (Pts) with hematologic malignancies (HM) are at greater risk of severe morbidity and mortality caused by COVID19 and show a lower...

Original Article from The New England Journal of Medicine — Early Outpatient Treatment for Covid-19 with Convalescent...